Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: A systematic review

BMJ Open

Volumn 6, Issue 6, 2016, Pages

  Ravnskov, Uffe ^a   Diamond, David M ^b   Hama, Rokura ^c   Hamazaki, Tomohito ^d   Hammarskjöld, Björn ^e   Hynes, Niamh ^f   Kendrick, Malcolm ^g   Langsjoen, Peter H ^h   Malhotra, Aseem ⁱ   Mascitelli, Luca ^j   McCully, Kilmer S ^k   Ogushi, Yoichi ^l   Okuyama, Harumi ^m   Rosch, Paul J ⁿ   Schersten, Tore ^o,p   Sultan, Sherif ^f   Sundberg, Ralf ^q  

^a University of South Florida ^*  (Sweden)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NPO   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e Nordic Institute for Advanced Study   (Sweden)

^f NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^g MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^h Clinical Cardiology Practice   (United States)

ⁱ FRIMLEY PARK HOSPITAL   (United Kingdom)

^j Medical Service   (Italy)

^k HARVARD MEDICAL SCHOOL   (United States)

^l TOKAI UNIVERSITY   (Japan)

^m NAGOYA CITY UNIVERSITY   (Japan)

ⁿ NEW YORK MEDICAL COLLEGE   (United States)

^o UNIVERSITY OF GOTHENBURG   (Sweden)

^p Howard Hughes Medical Institute   (United States)

^q Slottsstadens Läkarhus   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; VEGETABLE OIL;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MORTALITY; SYSTEMATIC REVIEW; AGED; BLOOD; MIDDLE AGED; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; HUMANS; MIDDLE AGED; MORTALITY; RISK FACTORS;

EID: 84975215551     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010401     Document Type: Article

References (40)

1. Ravnskov U. Is atherosclerosis caused by high cholesterol? QJM 2002;95:397-403.
2. Hamazaki T, Okuyama H, Ogushi Y, et al. Towards a paradigm shift in cholesterol treatment-a re-examination of the cholesterol issue in Japan. Ann Nutr Metab 2015;66(Suppl 4):1-116.
3. Prospective Studies CollaborationLewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39.
4. Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell 2015;161:161-72.
5. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5.
6. Psaty BM,erson M, Kronmal RA, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, total mortality: the Cardiovascular Health Study. J Am Geriatr Soc 2004;52:1639-47.
7. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998;279:585-92.
8. Zimetbaum P, Frishman WH, Ooi WL, et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly: the Bronx Aging Study. Arterioscler Thromb 1992;12:416-23.
9. Kronmal RA, Cain KC, Ye Z, et al. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993;153:1065-73.
10. Raïhä I, Marniemi J, Puukka P, et al. Effect of serum lipids, lipoproteins, apolipoproteins on vascular and nonvascular mortality in the elderly. Arterioscler Thromb Vasc Biol 1997;17:1224-32.
11. Chyou PH, Eaker ED. Serum cholesterol concentrations and all-cause mortality in older people. Age Ageing 2000;29:69-74.
12. Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, et al. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003;163:1549-54.
13. Schupf N, Costa R, Luchsinger J, et al. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc 2005;53:219-26.
14. Tikhonoff V, Casiglia E, Mazza A, et al. Low-density lipoprotein cholesterol and mortality in older people. J Amer Geriatr Soc 2005;53:2159-64.
15. Störk S, Feelders RA, van den Beld AW, et al. Prediction of mortality risk in the elderly. Am J Med 2006;119:519-25.
16. Akerblom JL, Costa R, Luchsinger JA, et al. Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing 2008;37:207-13.
17. Upmeier E, Lavonius S, Lehtonen A, et al. Serum lipids and their association with mortality in the elderly: a prospective cohort study. Aging Clin Exp Res 2009;21:424-30.
18. Nilsson G, Ohrvik J, Lönnberg I, et al. Ten-year survival in 75-year-old men and women: predictive ability of total cholesterol, HDL-C, LDL-C. Curr Gerontol Geriatr Res 2009:158425. doi:10.1155/2009/158425
19. Werle MH, Moriguchi E, Fuchs SC, et al. Risk factors for cardiovascular disease in the very elderly: results of a cohort study in a city in southern Brazil. Eur J Cardiovasc Prev Rehabil 2011;18:369-77.
20. Bathum L, Depont Christensen R, Engers Pedersen L, et al. Association of lipoprotein levels with mortality in subjects aged 50 +without previous diabetes or cardiovascular disease: a population-based register study. Scand J Prim Health Care 2013;31:172-80.
21. Linna M, Ahotupa M, Löppönen MK, et al. Circulating oxidised LDL lipids, when proportioned to HDL-C emerged as a risk factor of all-cause mortality in a population-based survival study. Age Ageing 2013;42:110-13.
22. Jacobs JM, Cohen A, Ein-Mor E, et al. Cholesterol, statins, longevity from age 70 to 90 years. J Am Med Dir Assoc 2013;14:883-8.
23. Takata Y, Ansai T, Soh I, et al. Serum total cholesterol concentration and 10-year mortality in an 85-year-old population. Clin Interv Aging 2014;9:293-300.
24. Lv YB, Yin ZX, Chei CL, et al. Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey. Atherosclerosis 2015;239: 137-42.
25. Blekkenhorst LC, Prince RL, Hodgson JM, et al. Dietary saturated fat intake and atherosclerotic vascular disease mortality in elderly women: a prospective cohort study. Am J Clin Nutr 2015;101:1263-8.
26. Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016;353: i1246.
27. Ravnskov U, McCully KS. Vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann Clin Lab Sci 2009;39:3-16.
28. Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM 2003;96:927-34.
29. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-60.
30. Iribarren C, Jacobs DR Jr, Sidney S, et al. Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiol Infect 1998;121:335-47.
31. Read SA, Douglas MW. Virus induced inflammation and cancer development. Cancer Lett 2014;345:174-81.
32. Ravnskov U, McCully KS, Rosch PJ. The statin-low cholesterol-cancer conundrum. QJM 2012;105:383-8.
33. Newman TB, Hulley SB. Carcinogenicity of lipid-lowering drugs. JAMA 1996;275:55-60.
34. Neil HA, Hawkins MM, Durrington PN, et al. Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study. Atherosclerosis 2005;179:293-7.
35. Reddy VS, Bui QT, Jacobs JR, et al. Relationship between serum low-density lipoprotein cholesterol and In-hospital mortality following acute myocardial infarction (The lipid paradox). Am J Cardiol 2015;115:557-62.
36. Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in get with the guidelines. Am Heart J 2009;157:111-17.
37. Al-Mallah MH, Hatahet H, Cavalcante JL, et al. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction. Cardiol J 2009;16:227-33.
38. Diamond DM, Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharmacol 2015;8:201-10.
39. Kristensen ML, Christensen PM, Hallas J. The effect of statins on average survival in randomised trials, an analysis of end point postponement. BMJ Open 2015;5:e007118.
40. de Lorgeril M, Rabaeus M. Beyond confusion and controversy, Can we evaluate the real efficacy and safety of cholesterol-lowering with statins? J Controversies Biomed Res 2015;1:67-92.